Literature DB >> 19744893

Temporal lobe functional activity and connectivity in young adult APOE varepsilon4 carriers.

Nancy A Dennis1, Jeffrey N Browndyke, Jared Stokes, Anna Need, James R Burke, Kathleen A Welsh-Bohmer, Roberto Cabeza.   

Abstract

BACKGROUND: We sought to determine if the APOE epsilon4 allele influences both the functional activation and connectivity of the medial temporal lobes (MTLs) during successful memory encoding in young adults.
METHODS: Twenty-four healthy young adults, i.e., 12 carriers and 12 noncarriers of the APOE epsilon4 allele, were scanned in a subsequent-memory paradigm, using event-related functional magnetic resonance imaging. The neuroanatomic correlates of successful encoding were measured as greater neural activity for subsequently remembered versus forgotten task items, or in short, encoding success activity (ESA). Group differences in ESA within the MTLs, as well as whole-brain functional connectivity with the MTLs, were assessed.
RESULTS: In the absence of demographic or performance differences, APOE epsilon4 allele carriers exhibited greater bilateral MTL activity relative to noncarriers while accomplishing the same encoding task. Moreover, whereas epsilon4 carriers demonstrated a greater functional connectivity of ESA-related MTL activity with the posterior cingulate and other peri-limbic regions, reductions in overall connectivity were found across the anterior and posterior cortices.
CONCLUSIONS: These results suggest that the APOE varepsilon4 allele may influence not only functional activations within the MTL, but functional connectivity of the MTLs to other regions implicated in memory encoding. Enhanced functional connectivity of the MTLs with the posterior cingulate in young adult epsilon4 carriers suggests that APOE may be expressed early in brain regions known to be involved in Alzheimer's disease, long before late-onset dementia is a practical risk or consideration. These functional connectivity differences may also reflect pleiotropic effects of APOE during early development. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19744893      PMCID: PMC2891943          DOI: 10.1016/j.jalz.2009.07.003

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  50 in total

1.  Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele.

Authors:  Heather A Wishart; Andrew J Saykin; Laura A Rabin; Robert B Santulli; Laura A Flashman; Stephen J Guerin; Alexander C Mamourian; Dorothy R Belloni; C Harker Rhodes; Thomas W McAllister
Journal:  Am J Psychiatry       Date:  2006-09       Impact factor: 18.112

2.  Measuring functional connectivity during distinct stages of a cognitive task.

Authors:  Jesse Rissman; Adam Gazzaley; Mark D'Esposito
Journal:  Neuroimage       Date:  2004-10       Impact factor: 6.556

3.  Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism.

Authors:  Eric M Reiman; Kewei Chen; Gene E Alexander; Richard J Caselli; Daniel Bandy; David Osborne; Ann M Saunders; John Hardy
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-02       Impact factor: 11.205

4.  Functional magnetic resonance imaging and magnetoencephalography differences associated with APOEepsilon4 in young healthy adults.

Authors:  Francesca M Filbey; Kelly J Slack; Trey P Sunderland; Robert M Cohen
Journal:  Neuroreport       Date:  2006-10-23       Impact factor: 1.837

5.  Verbal paired-associate learning by APOE genotype in non-demented older adults: fMRI evidence of a right hemispheric compensatory response.

Authors:  S Duke Han; Wes S Houston; Amy J Jak; Lisa T Eyler; Bonnie J Nagel; Adam S Fleisher; Gregory G Brown; Jody Corey-Bloom; David P Salmon; Leon J Thal; Mark W Bondi
Journal:  Neurobiol Aging       Date:  2006-01-24       Impact factor: 4.673

6.  Effect of apolipoprotein E allele epsilon4 on the initial phase of amyloid beta-protein accumulation in the human brain.

Authors:  M Morishima-Kawashima; N Oshima; H Ogata; H Yamaguchi; M Yoshimura; S Sugihara; Y Ihara
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

7.  A standardized set of 260 pictures: norms for name agreement, image agreement, familiarity, and visual complexity.

Authors:  J G Snodgrass; M Vanderwart
Journal:  J Exp Psychol Hum Learn       Date:  1980-03

8.  Medial temporal structures relate to memory impairment in Alzheimer's disease: an MRI volumetric study.

Authors:  E Mori; Y Yoneda; H Yamashita; N Hirono; M Ikeda; A Yamadori
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-08       Impact factor: 10.154

9.  Incidence and risk factors for mild cognitive impairment: a population-based three-year follow-up study of cognitively healthy elderly subjects.

Authors:  Susanna Tervo; Miia Kivipelto; Tuomo Hänninen; Matti Vanhanen; Merja Hallikainen; Arto Mannermaa; Hilkka Soininen
Journal:  Dement Geriatr Cogn Disord       Date:  2004-01-20       Impact factor: 2.959

10.  Correlations between apolipoprotein E epsilon4 gene dose and whole brain atrophy rates.

Authors:  Kewei Chen; Eric M Reiman; Gene E Alexander; Richard J Caselli; Richard Gerkin; Daniel Bandy; Alisa Domb; David Osborne; Nick Fox; William R Crum; Ann M Saunders; John Hardy
Journal:  Am J Psychiatry       Date:  2007-06       Impact factor: 18.112

View more
  100 in total

Review 1.  Episodic memory on the path to Alzheimer's disease.

Authors:  Michela Gallagher; Ming Teng Koh
Journal:  Curr Opin Neurobiol       Date:  2011-11-11       Impact factor: 6.627

2.  Gray matter network associated with risk for Alzheimer's disease in young to middle-aged adults.

Authors:  Gene E Alexander; Kaitlin L Bergfield; Kewei Chen; Eric M Reiman; Krista D Hanson; Lan Lin; Daniel Bandy; Richard J Caselli; James R Moeller
Journal:  Neurobiol Aging       Date:  2012-03-08       Impact factor: 4.673

Review 3.  The cognitive neuroscience of ageing.

Authors:  Cheryl Grady
Journal:  Nat Rev Neurosci       Date:  2012-06-20       Impact factor: 34.870

Review 4.  Potential of GABA-ergic cell therapy for schizophrenia, neuropathic pain, and Alzheimer's and Parkinson's diseases.

Authors:  Ashok K Shetty; Adrian Bates
Journal:  Brain Res       Date:  2015-09-28       Impact factor: 3.252

5.  A combined effect of two Alzheimer's risk genes on medial temporal activity during executive attention in young adults.

Authors:  Adam E Green; Jeremy R Gray; Colin G Deyoung; Timothy R Mhyre; Robert Padilla; Amanda M Dibattista; G William Rebeck
Journal:  Neuropsychologia       Date:  2014-01-02       Impact factor: 3.139

6.  Longitudinal change in working memory as a function of APOE genotype in midlife and old age.

Authors:  Pamela M Greenwood; Thomas Espeseth; Ming-Kuan Lin; Ivar Reinvang; Raja Parasuraman
Journal:  Scand J Psychol       Date:  2014-06

7.  Opposite Neural Trajectories of Apolipoprotein E ϵ4 and ϵ2 Alleles with Aging Associated with Different Risks of Alzheimer's Disease.

Authors:  Hao Shu; Yongmei Shi; Gang Chen; Zan Wang; Duan Liu; Chunxian Yue; B Douglas Ward; Wenjun Li; Zhan Xu; Guangyu Chen; Qihao Guo; Jun Xu; Shi-Jiang Li; Zhijun Zhang
Journal:  Cereb Cortex       Date:  2014-10-21       Impact factor: 5.357

8.  Tau Accumulation in Clinically Normal Older Adults Is Associated with Hippocampal Hyperactivity.

Authors:  Willem Huijbers; Aaron P Schultz; Kathryn V Papp; Molly R LaPoint; Bernard Hanseeuw; Jasmeer P Chhatwal; Trey Hedden; Keith A Johnson; Reisa A Sperling
Journal:  J Neurosci       Date:  2018-11-27       Impact factor: 6.167

9.  APOE ε4 status in healthy older African Americans is associated with deficits in pattern separation and hippocampal hyperactivation.

Authors:  Neha Sinha; Chelsie N Berg; Nicholas J Tustison; Ashlee Shaw; Diane Hill; Michael A Yassa; Mark A Gluck
Journal:  Neurobiol Aging       Date:  2018-05-26       Impact factor: 4.673

10.  Attentional performance, impulsivity, and related neurotransmitter systems in apoE2, apoE3, and apoE4 female transgenic mice.

Authors:  Ingrid Reverte; Fiona Peris-Sampedro; Pia Basaure; Leticia Campa; Cristina Suñol; Margarita Moreno; José Luis Domingo; Maria Teresa Colomina
Journal:  Psychopharmacology (Berl)       Date:  2016-01       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.